Evidence for label-retaining tumour-initiating cells in human glioblastoma

Al-Hajj, 2003, Prospective identification of tumourigenic breast cancer cells, Proc Natl Acad Sci USA, 100, 3983, 10.1073/pnas.0530291100

Anderson, 2003, Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy, Prog Cell Cycle Res, 5, 423

Bao, 2006, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, 444, 756, 10.1038/nature05236

Bapat, 2005, Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer, Cancer Res, 65, 3025, 10.1158/0008-5472.CAN-04-3931

Bar, 2007, Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma, Stem Cells, 25, 2524, 10.1634/stemcells.2007-0166

Barnes, 2006, Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia, Cell Cycle, 5, 2862, 10.4161/cc.5.24.3573

Beier, 2007, CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles, Cancer Res, 67, 4010, 10.1158/0008-5472.CAN-06-4180

Bidlingmaier, 2008, The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells, J Mol Med, 86, 1025, 10.1007/s00109-008-0357-8

Bleau, 2009, PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumour stem-like cells, Cell Stem Cell, 4, 226, 10.1016/j.stem.2009.01.007

Blow, 2002, Replication licensing–defining the proliferative state?, Trends Cell Biol, 12, 72, 10.1016/S0962-8924(01)02203-6

Brennan, 2009, Tight junctions: a barrier to the initiation and progression of breast cancer?, J Biomed Biotechnol, 2010, 460607

Chen, 2010, A hierarchy of self-renewing tumour-initiating cell types in glioblastoma, Cancer Cell, 17, 362, 10.1016/j.ccr.2009.12.049

Cheng, 2009, How powerful is CD133 as a cancer stem cell marker in brain tumours?, Cancer Treat Rev, 35, 403, 10.1016/j.ctrv.2009.03.002

Collins, 2005, Prospective identification of tumourigenic prostate cancer stem cells, Cancer Res, 65, 10946, 10.1158/0008-5472.CAN-05-2018

Deleyrolle, 2009, Isolation, expansion, and differentiation of adult mammalian neural stem and progenitor cells using the neurosphere assay, Methods Mol Biol, 549, 91, 10.1007/978-1-60327-931-4_7

Dembinski, 2009, Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma, Clin Exp Metastasis, 26, 611, 10.1007/s10585-009-9260-0

Eramo, 2008, Identification and expansion of the tumourigenic lung cancer stem cell population, Cell Death Differ, 15, 504, 10.1038/sj.cdd.4402283

Galli, 2004, Isolation and characterization of tumourigenic, stem-like neural precursors from human glioblastoma, Cancer Res, 64, 7011, 10.1158/0008-5472.CAN-04-1364

Golmohammadi, 2008, Comparative analysis of the frequency and distribution of stem and progenitor cells in the adult mouse brain, Stem Cells, 26, 979, 10.1634/stemcells.2007-0919

Graham, 2002, Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro, Blood, 99, 319, 10.1182/blood.V99.1.319

Griguer, 2008, CD133 is a marker of bioenergetic stress in human glioma, PLoS ONE, 3, e3655, 10.1371/journal.pone.0003655

Holyoake, 1999, Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia, Blood, 94, 2056, 10.1182/blood.V94.6.2056

Holyoake, 2001, Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3, Blood, 97, 720, 10.1182/blood.V97.3.720

Hu, 2009, ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays, J Immunol Methods, 347, 70, 10.1016/j.jim.2009.06.008

Ignatova, 2002, Human cortical glial tumours contain neural stem-like cells expressing astroglial and neuronal markers in vitro, Glia, 39, 193, 10.1002/glia.10094

Joo, 2008, Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas, Lab Invest, 88, 808, 10.1038/labinvest.2008.57

Kast, 2009, Suppressing glioblastoma stem cell function by aldehyde dehydrogenase inhibition with chloramphenicol or disulfiram as a new treatment adjunct: an hypothesis, Curr Stem Cell Res Ther, 4, 314, 10.2174/157488809789649241

Kelly, 2009, Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens, Stem Cells, 27, 1722, 10.1002/stem.98

Kondo, 2004, Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line, Proc Natl Acad Sci USA, 101, 781, 10.1073/pnas.0307618100

Krishnamurthy, 2008, Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide, Breast Cancer Res, 10, R106, 10.1186/bcr2211

Laks, 2009, Neurosphere formation is an independent predictor of clinical outcome in malignant glioma, Stem Cells, 27, 980, 10.1002/stem.15

Lapidot, 1994, A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, 367, 645, 10.1038/367645a0

Lee, 2006, Tumour stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumours than do serum-cultured cell lines, Cancer Cell, 9, 391, 10.1016/j.ccr.2006.03.030

Lei, 2005, The MCM complex: its role in DNA replication and implications for cancer therapy, Curr Cancer Drug Targets, 5, 365, 10.2174/1568009054629654

Li, 2007, Identification of pancreatic cancer stem cells, Cancer Res, 67, 1030, 10.1158/0008-5472.CAN-06-2030

Louis, 2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, 114, 97, 10.1007/s00401-007-0243-4

Lyons, 2000, Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution, J Immunol Methods, 243, 147, 10.1016/S0022-1759(00)00231-3

Nishide, 2009, Glioblastoma formation from cell population depleted of Prominin1-expressing cells, PLoS ONE, 4, e6869, 10.1371/journal.pone.0006869

Ogden, 2008, Identification of A2B5+CD133- tumour-initiating cells in adult human gliomas, Neurosurgery, 62, 505, 10.1227/01.neu.0000316019.28421.95

Patrawala, 2005, Side population is enriched in tumourigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumourigenic, Cancer Res, 65, 6207, 10.1158/0008-5472.CAN-05-0592

Pece, 2010, Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content, Cell, 140, 62, 10.1016/j.cell.2009.12.007

Piccirillo, 2006, Bone morphogenetic proteins inhibit the tumourigenic potential of human brain tumour-initiating cells, Nature, 444, 761, 10.1038/nature05349

Qian, 2010, Macrophage diversity enhances tumour progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014

Rasper, 2010, Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumour stem cell capacity, Neuro Oncol, 12, 1024, 10.1093/neuonc/noq070

Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167

Ricci-Vitiani, 2007, Identification and expansion of human colon-cancer-initiating cells, Nature, 445, 111, 10.1038/nature05384

Roesch, 2010, A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumour growth, Cell, 141, 583, 10.1016/j.cell.2010.04.020

Semple, 2004, ORC-associated replication factors as biomarkers for cancer, Biotechnol Adv, 22, 621, 10.1016/j.biotechadv.2004.06.001

Shackleton, 2009, Heterogeneity in cancer: cancer stem cells versus clonal evolution, Cell, 138, 822, 10.1016/j.cell.2009.08.017

Singh, 2003, Identification of a cancer stem cell in human brain tumours, Cancer Res, 63, 5821

Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128

Son, 2009, SSEA-1 is an enrichment marker for tumour-initiating cells in human glioblastoma, Cell Stem Cell, 4, 440, 10.1016/j.stem.2009.03.003

Suetsugu, 2006, Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells, Biochem Biophys Res Commun, 351, 820, 10.1016/j.bbrc.2006.10.128

Suva, 2009, Identification of cancer stem cells in Ewing’s sarcoma, Cancer Res, 69, 1776, 10.1158/0008-5472.CAN-08-2242

Tchoghandjian, 2010, A2B5 cells from human glioblastoma have cancer stem cell properties, Brain Pathol, 20, 211, 10.1111/j.1750-3639.2009.00269.x

Vescovi, 2006, Brain tumour stem cells, Nat Rev Cancer, 6, 425, 10.1038/nrc1889

Wang, 2008, CD133 negative glioma cells form tumours in nude rats and give rise to CD133 positive cells, Int J Cancer, 122, 761, 10.1002/ijc.23130

Witz, 2009, The tumour microenvironment: the making of a paradigm, Cancer Microenviron, 2, 9, 10.1007/s12307-009-0025-8

Wong, 2009, Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas, J Clin Neurosci, 16, 1119, 10.1016/j.jocn.2009.02.009

Zhou, 2003, Targeting DNA checkpoint kinases in cancer therapy, Cancer Biol Ther, 2, S16, 10.4161/cbt.200